Роль порушень гемостазу в розвитку і прогресуванні гломерулонефритів (огляд літератури)

Автор(и)

  • I. S. Mykhaloiko

DOI:

https://doi.org/10.24061/2413-0737.XXIII.1.89.2019.18

Ключові слова:

гломерулонефрит, гемостаз, дисфункція ендотелію, прокоагулянти, антикоагулянти

Анотація

Мета роботи — викласти останні дані літератури щодо порушень гемостазу у хворих на гломерулонефрит.
Висновок. Проведений аналіз даних дозволив узагальнити існуючі дані та визначити перспективи подальших досліджень порушень системи гемостазу при гломерулонефритах на основі визначення коагуляційного гемостазу сечі.

Посилання

Hemker HC. The application of thrombin generation in real life clinical situations. Thromb Res. 2015;136(1):3-4.

Alsharidah SA, Bayoumy NM, Alzogaibi MA, Owaidah T, Alghonaim M. Thrombin generation and endothelial dysfunctional markers in different stages of nephrotic syndrome. J App Hematol. 2016;7:118-23.

Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton). 2012;17(4):338-45.

Movchan EA. Disfunktsiya endoteliya i trombotsitov pri khronicheskoy bolezni pochek: novyy vzglyad na staruyu problemu narusheniy v sisteme gemostaza u bol'nykh glomerulonefritom [Endothelial and platelet dysfunction in chronic kidney disease: a new look at the old problem of disorders in the hemostasis system in patients with glomerulonephritis]. Byulleten' sibirskoy meditsiny. 2008;2:82-96. (in Russian).

Zelenin KN, Esayan AM, Rumyantsev ASh. Otsenka funktsional'noy aktivnosti trombotsitov pri khronicheskoy bolezni pochek stadii 5d [Evaluation of platelet functional activity in chronic stage 5d kidney disease]. Al'manakh klinicheskoy meditsiny. 2017;45(7):547-52. (in Russian).

Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost. 2010;36(1):34-40.

Papayan KA, Savenkova ND, Golovina OG, Papayan LP, Kachanova TL. Osobennosti sostoyaniya gemostaza detey, bol'nykh khronicheskim glomerulonefritom [Features of the state of hemostasis in children with chronic glomerulonephritis]. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya. 2014;13(4):28-33. (in Russian).

Momose A, Nakajima T, Chiba S, Kumakawa K, Shiraiwa Y, Sasaki N, et al. A Case of Fibrillary Glomerulonephritis Associated with Thrombotic Microangiopathy and Anti-Glomerular Basement Membrane Antibody. Nephron Extra. 2015;5(1):30-8.

Sibireva OF, Serebrov VYu, Kanskaya NV, Zhavoronok TV, Pozdnyakova IA, Stepanova EA. Vliyanie faktorov vospaleniya na pokazateli svertyvayushchey sistemy krovi pri pochechnoy patologii [Influence of inflammation factors on blood coagulation parameters in renal pathology]. Sibirskiy meditsinskiy zhurnal. 2016;31(1):49-56. (in Russian).

Muravleva LE, Molotov-Luchanskiy VB, Klyuev DA. Gemostaz pri khronicheskoy bolezni pochek. Miniobzor [Hemostasis in chronic kidney disease. Mini review]. Sovremennye problemy nauki i obrazovaniya. 2010;4:39-42. (in Russian).

Storozhuk OB, Selezn'ova IB, Storozhuk LO, Storozhuk BH, Dovhaliuk TV. Osoblyvosti stanu systemy hemostazu u khvorykh na KhKhN V D stadii, scho likuiut'sia prohramnym hemodializom ta infikovani virusamy hepatytiv V i S [Peculiarities of the state of the hemostasis system in patients with CKD V D stages treated with programmed hemodialysis and infected with hepatitis B and C viruses]. Visnyk problem biolohii i medytsyny. 2018;1:142-49. (in Ukrainian).

Hughes S, Szeki I, Nash MJ, Thachil J. Anticoagulation in chronic kidney disease patients-the practical aspects. Clin Kidney J. 2014;7(5):442-9.

Yi-Heng L, Cheng-Hsiang K, Guey-Yueh S, Hua-Lin W. The role of thrombomodulin lectin-like domain in inflammation. Journal of Biomedical Science. 2012;19:34.

Mel'nik AA. Sistema gemostaza i ee regulyatsiya pri narushenii funktsional'noy sposobnosti pochek [The system of hemostasis and its regulation in violation of the functional ability of the kidneys]. Pochki. 2016;3:57-62. (in Russian).

Domingueti CP, Foscolo RB, Reis JS, Campos FMF, Dusse LMS, Carvalho MDG, et al. Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus. Journal of Diabetes Research. 2016. http://dx.doi.org/10.1155/2016/2315260.

Barbano B, Gigante A, Amoroso A, Cianci R. Thrombosis in nephrotic syndrome. Semin Thromb Hemost. 2013;39(5):469-76.

Ismail G, Mircescu G, Ditoiu AV, Tacu BD, Jurubita R, Harza M. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters. Int Urol Nephrol. 2014;46(4):787-92.

Bauer A, Limperger V, Nowak-Göttl U. End-stage renal disease and thrombophilia. Hamostaseologie. 2016;36(2):103-7.

Litvitskii PF. Pathology of the Hemostatic System. Voprosy sovremennoi pediatrii. Current Pediatrics. 2014;13(2):65-76.

Shul'kina SG, Smirnova VG, Zhelobov AK. Klinicheskoe znachenie markerov endotelial'noy disfunktsii v diagnostike funktsional'nogo sostoyaniya pochek u bol'nykh s arterial'noy gipertenziey v sochetanii s ozhirenniem [The clinical significance of endothelial dysfunction markers in the diagnosis of renal function in patients with arterial hypertension in combination with obesity]. The Journal of scientific articles “Health and Education Millennium”. 2016;18(5):19-25. (in Russian).

Weiler H, Isermann BH. Thrombomodulin. J Thromb Haemost. 2003;1(7):1515-524.

##submission.downloads##

Опубліковано

2019-03-30

Номер

Розділ

НАУКОВІ ОГЛЯДИ